Treatment of elevated blood pressure in diabetic patients.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of diabetes and its complications

• Publication date

  1997-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1056-8727(96)00093-1PMID 9101394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Lipoproteins During Treatment with Antihypertensive Drugs

  2012cited by this paper
• Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension

  2004cited by this paper
• Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

  2004cited by this paper
• Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

  1996cited by this paper
• Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes

  1996cited by this paper
• Alcohol and blood pressure--a drink a day...

  1995cited by this paper
• A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM

  1995cited by this paper
• Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy.

  1995cited by this paper
• The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

  1995cited by this paper
• Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?

  1995cited by this paper
• Suppression of alcohol-induced hypertension by dexamethasone.

  1995cited by this paper
• Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus.

  1995cited by this paper
• Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.

  1995cited by this paper
• Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.

  1995cited by this paper
• Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.

  1994cited by this paper
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

  1994cited by this paper
• Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.

  1994cited by this paper
• Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients.

  1994cited by this paper
• Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension.

  1994cited by this paper
• Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells.

  1994cited by this paper
• Declining incidence of nephropathy in insulin-dependent diabetes mellitus.

  1994cited by this paper
• Hypertension: Pathophysiology, Diagnosis, and Management

  1994cited by this paper
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria

  1994cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients

  1993cited by this paper
• Pathogenesis and treatment of hypertension associated with diabetes mellitus.

  1993cited by this paper
• National High Blood Pressure Education Program Working Group report on primary prevention of hypertension.

  1993cited by this paper
• Effects of different antihypertensive drugs on human diabetic proteinuria.

  1993cited by this paper
• Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis.

  1993cited by this paper
• Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.

  1992cited by this paper
• [Improved glucose regulation and microalbuminuria/proteinuria in diabetic patients treated with ACE inhibitors. A meta-analysis of published studies of 1985-1990].

  1992cited by this paper
• Central Role of Sodium in Hypertension in Diabetic Subjects

  1991cited by this paper
• Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients

  1991cited by this paper
• Metabolic Effects of Isradipine Versus Hydrochlorothiazide in Diabetes Mellitus

  1991cited by this paper
• Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors

  1991cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

  1990cited by this paper
• Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

  1990cited by this paper
• A differing view of treatment of hypertension in patients with diabetes mellitus.

  1987cited by this paper
• Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

  1987cited by this paper
• Pathogenesis and treatment of hypertension associated with diabetes.

  1985cited by this paper
• Mortality and hardness of local water-supplies.

  1968cited by this paper
• Metabolic aspects of hypertension.

  1963cited by this paper
• Hydatid Disease

  1895cited by this paper

• Cardiorenal Protective Effects of Vasopeptidase Inhibition with Omapatrilat in Hypertensive Transgenic (mREN‐2)27 Rats

  2004cites this paper
• Antihypertensive drugs and diabetic nephropathy

  1999cites this paper
• Requirements for antihypertensive therapy in diabetic patients: metabolic aspects

  1997cites this paper